Prøve GULL - Gratis
₹1 trillion margin trading boom masks rising retail investor risk
Mint Mumbai
|March 23, 2026
Additional costs, such as interest, brokerage and haircuts on pledged shares, can materially impact returns
India’s margin trading market has crossed ₹1 trillion, underscoring a surge in leveraged stock buying even as risks for retail investors remain elevated.
Data from the National Stock Exchange shows outstanding funded positions across brokers have surpassed ₹1 trillion, highlighting the growing use of leverage in recent years.
The pitch is tempting: put in a fraction of the money, borrow the rest from your broker, and take a larger position in a stock you are bullish on. But the mechanics of margin trading facilities (MTF) carry risks that are easy to underestimate.
How it works
MTF lets investors buy stocks by paying a part of the transaction value upfront. Brokers fund the rest and charge interest on the borrowed amount, typically calculated daily. The upfront portion, or initial margin, can be met with cash or by pledging shares already held in a demat account. Investors effectively own the shares, but the position carries an interest cost for as long as it is held.
Not every stock is eligible. Only securities classified as Group I by exchanges—around 1,000 currently—can be bought or pledged under MTF. These are liquid stocks traded on at least 80% of days in the past six months. Maximum lending varies by investor, stock and broker risk policies, and access requires explicit opt-in through a broker's platform.
Leverage and costs
The exchange rules require investors to bring in 20-50% of the purchase value as margin, implying 2-5 times leverage. For a ₹1 lakh position, this translates to an upfront investment of ₹20,000-50,000, with the broker funding the rest. However, many brokers set higher margins depending on the stock, typically offering 2-4 times leverage.
Interest rates on the borrowed amount range from 9% to 18% per annum, depending on the broker. Some also charge pledging and unpledging fees when existing holdings are used as collateral.
Denne historien er fra March 23, 2026-utgaven av Mint Mumbai.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Mumbai
Mint Mumbai
Investors bet on large market swings to profit this week
Don ko samajana mushkil bhi nahi namumkin bhi hai (Understanding Don is not just difficult, but impossible), quipped market veteran Nilesh Shah, managing director of Kotak Mahindra Asset Management Co., as conflicting statements on the Iran war emanated from US President Donald Trump over the weekend.
2 mins
March 23, 2026
Mint Mumbai
'Writing about issues without specifics creates uncertainty'
The markets were not kind to HDFC Bank after it announced the abrupt exit of its chairman Atanu Chakraborty on 18 March.
3 mins
March 23, 2026
Mint Mumbai
How a temple event is bringing chiefs of Tata Sons, SP together
Ever since the ouster of Shapoorji Pallonji Group scion Cyrus Mistry as Tata Sons chairman in 2016, the two sides have had frosty relations.
2 mins
March 23, 2026
Mint Mumbai
Clean Energy Innovations Take Spotlight at the Technical Session
Day 3 session highlights hydropower stability, biomass solutions and rural EV innovation as key to sustainable energy transition
1 mins
March 23, 2026
Mint Mumbai
REVERENCE LOST IN RELENTLESS FESTIVAL NOISE
On the first day of the Vikram Samvat 2083 (the Hindu new year), I got up a little early.
3 mins
March 23, 2026
Mint Mumbai
Crude thinking: It's a bad idea for the US to toy with oil prices
Manipulating the oil futures market would be much too distortive
3 mins
March 23, 2026
Mint Mumbai
India's weight-loss drug party is roaring, but the regulator wants sanity to prevail
Just when the weight-loss party was kicking into high gear, the drug regulator has made an entry.
3 mins
March 23, 2026
Mint Mumbai
Homeopathy access likely to expand using allopathic retail networks
In a push for alternative medicines, India is planning to direct allopathic drug wholesale dealers to stock and distribute homoeopathy medicines in the world’s third-largest pharmaceutical market by volume, as per two officials and documents reviewed by Mint.
2 mins
March 23, 2026
Mint Mumbai
Tata chip unit raises $735 mn from banks
Dholera land zero-valued; banks want Tatas to retain 51% stake
3 mins
March 23, 2026
Mint Mumbai
Vedanta taps NCLAT on Adani's JAL deal
Anil Agarwal-led Vedanta Ltd has moved the National Company Law Appellate Tribunal (NCLAT) against the approval of Adani Enterprises Ltd’s ₹14,543 crore bid for bankrupt Jaiprakash Associates Ltd (JAL).
3 mins
March 23, 2026
Listen
Translate
Change font size

